A recent study conducted at the University of Tampere, Tampere University of Technology, Pirkanmaa Hospital District and Fimlab in Finland has concluded that an electronic nose (eNose) can be used to identify the most common ...
Jan 17, 2018
0
3
Ewing sarcomas – rare, aggressive childhood cancers – are derived from mesenchymal cells in bone and soft tissues, and children with metastatic disease have poor survival.
Oct 5, 2017
0
27
(HealthDay)—The age-adjusted U.S. cancer death rate decreased 25 percent from 1991 to 2014, which translates into 2.1 million fewer cancer deaths, according to an annual progress report published by the American Association ...
Sep 14, 2017
0
1
At least a dozen children who had heart surgery at Children's Hospital New Orleans between late May and July have infected incisions, apparently from contaminated equipment.
Sep 12, 2017
0
1
On July 24 Vanderbilt scientist Eric Skaar, Ph.D., MPH, summarized his group's latest paper in a tweet: "If S. aureus is going to drink our blood like a vampire, let's kill it with sunlight."
Aug 1, 2017
0
117
In a case report recently published by experts at Baylor College of Medicine in the journal Sports Health, sports medicine expert Dr. Theodore Shybut highlights the need to be aware of the potential risk of tendon ruptures ...
Jul 12, 2017
0
0
Today, a team of investigators at Children's Hospital Los Angeles launched OncoKidsSM, a next-generation sequencing-based panel specifically designed for pediatric cancers. OncoKids is intended to guide the diagnosis and ...
Jun 21, 2017
0
39
Rhabdomyosarcoma, a cancer made up of cells that normally develop into skeletal muscles, is the most common soft tissue cancer in children. If it is detected early and localized in certain areas, rhabdomyosarcoma is usually ...
Jun 19, 2017
0
23
A new testing and treatment approach led to shorter hospital stays for patients with Staphylococcus aureus bloodstream infections. Study results were presented at the ASM Microbe 2017 conference in New Orleans, LA, on June ...
Jun 5, 2017
0
0
An experimental cancer medicine called larotrectinib has shown promise treating a diverse range of cancers in people young and old, researchers said at a major cancer conference in the United States.
Jun 4, 2017
0
0
